| Treatment of ventricular arrhythmias in the elderly. | |
| | |
MedLine Citation:
|
PMID: 19384088 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Underlying causes of ventricular tachycardia (VT) or complex ventricular arrhythmias (VA) should be treated if possible. Antiarrhythmic drugs should not be administered to treat asymptomatic individuals with complex VA and no heart disease. Beta-blockers are the only antiarrhythmic drugs that have been documented to reduce mortality in patients with VT or complex VA. Radiofrequency catheter ablation of VT has been beneficial in treating selected patients with arrhythmogenic foci of monomorphic VT. The automatic implantable cardioverter-defibrillator (AICD) is the most effective treatment for patients with life-threatening VT or ventricular fibrillation. Patients with AICDs should be treated with biventricular pacing, not with dual-chamber rate-responsive pacing at a rate of 70/min. Patients with AICDs should also be treated with beta-blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin blockers. |
| | |
Authors:
|
Wilbert S Aronow |
Related Documents
:
|
12475098 - Advanced rhythm discrimination for implantable cardioverter defibrillators using electr... 12391418 - New perspectives on catheter-based ablation of ventricular tachycardia complicating cha... 18547438 - Automated external cardioversion defibrillation monitoring in cardiac arrest: a randomi... 3344658 - Sequential transvenous pacing and shock therapy for termination of sustained ventricula... 3002808 - Inotropic, chronotropic and coronary vasodilator potency of forskolin. 2029438 - Circadian variation in the frequency of onset of chest pain in acute myocardial infarct... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Cardiology in review Volume: 17 ISSN: 1538-4683 ISO Abbreviation: Cardiol Rev Publication Date: 2009 May-Jun |
Date Detail:
|
Created Date: 2009-04-22 Completed Date: 2009-06-23 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9304686 Medline TA: Cardiol Rev Country: United States |
Other Details:
|
Languages: eng Pagination: 136-46 Citation Subset: IM |
Affiliation:
|
Cardiology Division, Department of Medicine, New York Medical College, Valhalla, New York 10595, USA. wsaronow@aol.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Antagonists
/
therapeutic use Aged Aged, 80 and over Angiotensin-Converting Enzyme Inhibitors / therapeutic use Arrhythmias, Cardiac / therapy* Catheter Ablation Defibrillators, Implantable Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use Tachycardia, Ventricular / therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Antagonists; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Thiazolidinediones and congestive heart failure: a judicious balance of risks and benefits.
Next Document: Clevidipine: a novel ultra-short-acting calcium antagonist.